Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 21472777)

1.

Nucleosides accelerate inflammatory osteolysis, acting as distinct innate immune activators.

Pan G, Zheng R, Yang P, Li Y, Clancy JP, Liu J, Feng X, Garber DA, Spearman P, McDonald JM.

J Bone Miner Res. 2011 Aug;26(8):1913-25. doi: 10.1002/jbmr.400.

PMID:
21472777
2.

Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation.

Hirayama T, Dai S, Abbas S, Yamanaka Y, Abu-Amer Y.

Arthritis Rheum. 2005 Sep;52(9):2719-29.

3.

Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.

Lubberts E, Oppers-Walgreen B, Pettit AR, Van Den Bersselaar L, Joosten LA, Goldring SR, Gravallese EM, Van Den Berg WB.

Arthritis Rheum. 2002 Nov;46(11):3055-64.

4.

Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.

Ishizuka Y, Moriwaki S, Kawahara-Hanaoka M, Uemura Y, Serizawa I, Miyauchi M, Shibata S, Kanaya T, Takata T, Taniguchi N, Niida S.

J Bone Miner Res. 2007 Dec;22(12):1933-42.

PMID:
17680722
5.

Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice.

Seeling M, Hillenhoff U, David JP, Schett G, Tuckermann J, Lux A, Nimmerjahn F.

Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10729-34. doi: 10.1073/pnas.1301001110. Epub 2013 Jun 10.

6.

IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.

Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, van den Berg WB.

J Immunol. 2003 Mar 1;170(5):2655-62.

7.

Bone destruction in arthritis.

Gravallese EM.

Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii84-6. Review.

8.

Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis.

Clohisy JC, Roy BC, Biondo C, Frazier E, Willis D, Teitelbaum SL, Abu-Amer Y.

J Immunol. 2003 Nov 15;171(10):5547-53.

9.

CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.

Yu X, Huang Y, Collin-Osdoby P, Osdoby P.

J Bone Miner Res. 2004 Dec;19(12):2065-77. Epub 2004 Sep 20.

PMID:
15537451
10.

Possible involvement of MIP-1alpha in the recruitment of osteoclast progenitors to the distal tibia in rats with adjuvant-induced arthritis.

Toh K, Kukita T, Wu Z, Kukita A, Sandra F, Tang QY, Nomiyama H, Iijima T.

Lab Invest. 2004 Sep;84(9):1092-102.

11.

Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.

Jimi E, Aoki K, Saito H, D'Acquisto F, May MJ, Nakamura I, Sudo T, Kojima T, Okamoto F, Fukushima H, Okabe K, Ohya K, Ghosh S.

Nat Med. 2004 Jun;10(6):617-24. Epub 2004 May 23.

PMID:
15156202
13.

Freund's complete adjuvant induces arthritis in mice lacking a functional interferon-gamma receptor by triggering tumor necrosis factor alpha-driven osteoclastogenesis.

Geboes L, De Klerck B, Van Balen M, Kelchtermans H, Mitera T, Boon L, De Wolf-Peeters C, Matthys P.

Arthritis Rheum. 2007 Aug;56(8):2595-607.

14.

In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis.

Childs LM, Paschalis EP, Xing L, Dougall WC, Anderson D, Boskey AL, Puzas JE, Rosier RN, O'Keefe RJ, Boyce BF, Schwarz EM.

J Bone Miner Res. 2002 Feb;17(2):192-9.

PMID:
11811549
15.

Suppressors of cytokine signaling-1 and -3 regulate osteoclastogenesis in the presence of inflammatory cytokines.

Ohishi M, Matsumura Y, Aki D, Mashima R, Taniguchi K, Kobayashi T, Kukita T, Iwamoto Y, Yoshimura A.

J Immunol. 2005 Mar 1;174(5):3024-31.

16.

Mechanisms modulating inflammatory osteolysis: a review with insights into therapeutic targets.

Wei S, Siegal GP.

Pathol Res Pract. 2008;204(10):695-706. doi: 10.1016/j.prp.2008.07.002. Epub 2008 Aug 30. Review.

17.

Modulation of osteoclast function in bone by the immune system.

Quinn JM, Saleh H.

Mol Cell Endocrinol. 2009 Oct 30;310(1-2):40-51. doi: 10.1016/j.mce.2008.11.002. Epub 2008 Nov 14. Review.

PMID:
19056462
18.

Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.

Yip KH, Zheng MH, Feng HT, Steer JH, Joyce DA, Xu J.

J Bone Miner Res. 2004 Nov;19(11):1905-16. Epub 2004 Sep 27.

PMID:
15476591
19.

Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.

Rahman MM, Bhattacharya A, Fernandes G.

J Lipid Res. 2006 Aug;47(8):1739-48. Epub 2006 May 15.

20.

TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.

Saidenberg-Kermanac'h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, Cohen-Solal ME.

Bone. 2004 Nov;35(5):1200-7.

PMID:
15542046
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk